Top related persons:
Top related locs:
Top related orgs:

Search resuls for: "Ester Baiget"


11 mentions found


Novonesis CEO: We are delivering on our promises
  + stars: | 2024-06-18 | by ( ) www.cnbc.com   time to read: 1 min
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailNovonesis CEO: We are delivering on our promisesNovonesis CEO Ester Baiget says the company's upgraded guidance shows it is on the right track after its merger.
Persons: Ester Baiget
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailConsumer demand for baking continues to stabilize, Novonesis CEO saysEster Baiget, CEO of Novonesis, comments on the underlying trends driving demand for baking.
Persons: Ester Baiget
Ester Baiget, the CEO of biosolutions firm Novozymes, said that "roadblocks" usually stand in the way of companies producing sustainable solutions which needed to be removed. watch nowMicrobes have been put forward as an alternative to reduce the use of chemical fertilizers, which contribute to greenhouse gas emissions. However, new microbial fertilizers need to go through regulatory approval before going to market. We need to rethink regulation in regions like Europe." Kadri also said there was a "lack of competitiveness in Europe," referring to the difficulties faced by her sector.
Persons: Lukas Schulze, Ester Baiget, Novozymes, Baiget, Steve Sedgwick, Ilham Kadri, Kadri Organizations: Getty, CNBC, Economic Locations: Bergheim, Germany, Davos, Switzerland, Europe
We have a regulation that is based on the passed: Novozymes CEO
  + stars: | 2024-01-25 | by ( ) www.cnbc.com   time to read: 1 min
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailWe have a regulation that is based on the passed: Novozymes CEO"We have a regulation which is based on the past," Ester Baiget, the CEO of biosolutions firm Novozymes, told CNBC, pointing out that in her own sector it can take six years to register a new microbe (or microorganism) to replace fertilizers.
Persons: Ester Baiget, Novozymes Organizations: CNBC
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailNovozymes CEO is confident its merger with Chr. Hansen will close in Q1Novozymes CEO Ester Baiget discusses the Danish biotechnology company's planned combination with with fellow biotech firm Chr.
Persons: Hansen, Ester Baiget Organizations: Chr Locations: Danish
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailRegulation is still a 'roadblock' on the 'path to carbon neutrality,' Novozymes CEO saysEster Baiget, CEO of Novozymes, discusses progress toward climate goals and carbon neutrality, saying companies are still dealing with "roadblocks" including "regulation which is based on the past."
Persons: Ester Baiget
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailPortfolio diversity means growth witnessed despite recessionary pressures, says Novozymes CEOEster Baiget, CEO at Novozymes, discusses earnings, and explains the impacts of current macroeconomic conditions on the business.
Biotechnology firms Novozymes and Chr. Hansen agreed to combine in what will be the biggest-ever merger between two Danish companies. The new biosolutions group will have annual revenues of approximately 3.5 billion euros ($3.7 billion), the companies said. "Novozymes and Chr. Combining the two companies will create a global leader in biosolutions," Novo Holdings Chairman Lars Rebien Sørensen said.
Enzyme makers Novozymes and Chr. Hansen to merge
  + stars: | 2022-12-12 | by ( ) www.reuters.com   time to read: +2 min
Copenhagen, Dec 12 (Reuters) - Danish food ingredients and enzymes makers Novozymes (NZYMb.CO) and Chr. While both companies' main business is producing enzymes, Chr. Following an extended opening auction at the Copenhagen blue chip index on Monday morning, shares in Novozymes dropped 7.5%, while Chr. Hansen shares jumped more than 33%. Hansen will receive 1.53 new shares in Novozymes, each nominally worth 2 Danish crowns ($0.2830), for every share in Chr.
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailNovozymes is set to merge with Chr. Hansen as part of a historic dealEster Baiget, CEO of Novozymes, discusses the planned merger of bioscience firms Novozymes and Chr.
COP27: The private sector needs to step up, says Novozymes CEO
  + stars: | 2022-11-11 | by ( ) www.cnbc.com   time to read: 1 min
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailCOP27: The private sector needs to step up, says Novozymes CEOEster Baiget, Novozymes CEO, says there needs to be more dialogue.
Total: 11